A wide and complete range of diagnostic and therapeutic products.

More than 200 product references, 6 therapeutic lines, and the possibility of creating product references tailored to each patient: the abundance of possible combinations allows STALLERGENES to satisfy each doctor's prescription, according to the patient's special case.

Diagnosis:

For diagnostic use, STALLERGENES supplies medical professionals with a wide range of in vivo prick tests (prick-tests, IntraDermal Reaction and respiratory provocation test) as well as in vitro tests allowing confirmation of diagnosis (developed in association with bio-Mérieux).

Treatments:

Two forms of products are currently available: subcutaneous injections, and sublingual drops developed by the STALLERGENES' research team. 
 
Sublingual range:
In more than ten years of clinical trials conducted according to "GMP" (Good Medical Practice), STALLERGENES has demonstrated the efficacy and safety of the sublingual route.
 
Subcutaneous ranges:
In order to provide for the needs of each and every patient, the STALLERGENES group offers a wide range of allergen extracts for subcutaneous administration. These allergen extracts are adsorbed onto physiological adjuvants; either calcium phosphate or onto aluminium hydroxide.
 
Hymenoptera venom range:
Desensitisation protects against wasp's and bee's sting. 

Standardisation

STALLERGENES has already standardised 35 allergens and 4 others are currently undergoing standardisation.

Standardisation is designed to reduce the inherent variations between individual allergen extracts (geographical source, season or year of harvest, culture methods and extraction procedures) and to ensure reproducibility of these allergens from one batch to the next, for maximum efficacy and safety.

It is essential not only to maintain existing standards but also to carry out regular updates; thus for each allergen, the standardisation process is repeated every 5 years.

Desensitisation is an especially rigorous speciality that requires constant validation.

To top

NPPs* allow for the treatment of allergies caused by more than 150 allergens.
* Named Patient Product (of allergens)